SEC Form SD filed by Luna Innovations Incorporated
$LUNA
Biotechnology: Commercial Physical & Biological Resarch
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
_____________________________________
FORM SD
_____________________________________
LUNA INNOVATIONS INCORPORATED
(Exact name of registrant as specified in its charter)
_____________________________________
Delaware | 000-52008 | 54-1560050 | ||||||
(State or Other Jurisdiction of Incorporation or Organization) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||
301 First Street SW, Suite 200
Roanoke, VA 24011
(Address of Principal Executive Offices)
John Roiko
Chief Financial Officer
(540) 769-8400
(Name and telephone number, including area code, of the person to contact in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in the form applies:
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2023.
☐ Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended _____________.
Section 1 – Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
A copy of the Conflict Minerals Report of Luna Innovations Incorporated (“we”) is attached as Exhibit 1.01 and is available at http://www.lunainc.com, under SEC Filings in Investor Relations.
We have adopted a conflict minerals policy, which is available at http:// www.lunainc.com, under Corporate Governance in Investor Relations. This policy is not incorporated herein by reference.
Item 1.02 Exhibit
We have filed, as an exhibit to this Form SD, the Conflict Minerals Report required by Item 1.01.
Section 2 – Resource Extraction Issuer Disclosure
Item 2.01 Resource Extraction Issue Disclosure and Report
Not applicable.
Section 3 – Exhibits
Item 3.01 Exhibits
The following exhibit is filed as part of this report:
| Exhibit No. | Description | ||||
| 1.01 | |||||
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
| Luna Innovations Incorporated | ||||||||||||||
| Date: | May 30, 2024 | By: | /s/ John Roiko | |||||||||||
| John Roiko | ||||||||||||||
Chief Financial Officer (Principal Financial and Accounting Officer) | ||||||||||||||